Clinical Trials of Coronavirus Drugs Are Taking Longer Than Expected 2020/08/14 15:06:27 New York Times
Antibody trials sponsored by Regeneron and Eli Lilly are off to a slow start because of a dearth of tests, overwhelmed hospitals and reluctant patients.
Insulin Pens Market and COVID-19 Impact Assessment 2020-2030 Featuring Novo Nordisk, Eli Lilly & Co, Sanofi and Ypsomed - ResearchAndMarkets.com 2020/08/11 16:25:00 Business Wire
DUBLIN--(BUSINESS WIRE)--The "Insulin Pens (Diabetes Care Devices) - Global Market Analysis and Forecast Model (COVID-19 market impact)" report has been added to ResearchAndMarkets.com's offering. The market model is built to visualize quantitative market trends within Diabetes Care Devices therapeutic area. This model discusses in detail the impact of COVID-19 on Insulin Pens market for the year 2020 and beyond. Each of the covered 39 country's color-coded and fully-sourced market models are e
Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab 2020/08/10 07:02:46 Smarter Analyst
Eli Lilly (LLY) and Innovent Biologics have announced encouraging interim analysis data from ORIENT-11 at the virtual IASLC World Conference on Lung Cancer … The post Eli Lilly, Innovent Deliver Encouraging Lung Cancer Data For Sintilimab appeared first on Smarter Analyst .
Australia experiencing critical shortage of antidepressants, contraceptives and HRT 2020/08/07 20:00:49 The Guardian
Reasons for shortages are often unclear and substitutes, which are not subsidised by PBS, are prohibitively expensive Australia is experiencing a critical shortage of key drugs including antidepressants, contraceptives and hormone replacement therapies, a situation that experts say highlights systemic problems with medicine supply in the country. Most of the shortages appear unrelated to coronavirus disruptions, although in the case of the popular antidepressant Prozac, the manufacturer, Eli Lilly, cites “unexpected increase in demand” during the crisis. Other manufacturers refuse to detail reasons for the supply problems. Continue reading…
Eli Lilly Antibody Treatment Can Be Nursing Home 'Safety Net', Says Coronavirus Research VP 2020/08/07 18:07:35 Cheddar
With coronavirus affecting the senior population particularly hard, pharmaceutical company, Eli Lilly, is developing an COVID-19 antibody treatment meant to protect aging senior, particularly those in assisted living facilities.